{"disease":{"id":"lipoprotein-lipase-deficiency","name":"lipoprotein lipase deficiency"},"drugs":{"marketed":[{"drug_id":"alipogene-tiparvovec","indication_name":"Familial lipoprotein lipase deficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Glybera","generic_name":"ALIPOGENE TIPARVOVEC","company_name":"uniQure biopharma B.V.","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":25,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02658175","title":"The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Chylomicronemia Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Akcea Therapeutics","has_results":true},{"nct_id":"NCT04227678","title":"Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency","phase":"NA","overall_status":"RECRUITING","enrollment_count":16,"lead_sponsor_name":"Université de Sherbrooke","has_results":false},{"nct_id":"NCT03360747","title":"Phase 2 Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Chylomicronemia Syndrome (FCS)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"Akcea Therapeutics","has_results":true},{"nct_id":"NCT03198897","title":"Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH)","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"CENTOGENE GmbH Rostock","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}